Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 48, 2008, Pages 18936-18941

  Hedlund, Maria ^a   Padler Karavani, Vered ^a   Varki, Nissi M ^a   Varki, Ajit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibodies; COX 2; Neu5Gc; Red meat; Sialic acid

Indexed keywords

ANTIBODY; CYCLOOXYGENASE 2 INHIBITOR; GLYCAN; HETEROPHILE ANTIBODY; N GLYCOLOYLNEURAMINIC ACID; ONCOFETAL ANTIGEN; SIALIC ACID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER RISK; CELL INFILTRATION; CHRONIC INFLAMMATION; DIET; ENZYME SYNTHESIS; GENETIC DISORDER; INFLAMMATION; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RED MEAT; RISK REDUCTION;

ANIMALS; ANTIBODIES, HETEROPHILE; CARCINOMA; CYCLOOXYGENASE 2; DIET; DISEASE PROGRESSION; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAMINIC ACIDS; RISK FACTORS;

ANIMALIA; MAMMALIA; MURINAE; MUS;

EID: 57749083520     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0803943105     Document Type: Article

References (53)

1. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo-(glyco)lipid metabolism. Cancer Res 56:5309-5318.
2. Chou HH, et al. (1998) Amutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 95:11751-11756.
3. Irie A, Koyama S, Kozutsumi Y, Kawasaki T, Suzuki A (1998) The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem 273:15866-15871.
4. Higashi H, et al. (1984) Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers. Gann 75:1025-1029.
5. Hirabayashi Y, Higashi H, Kato S, Taniguchi M, Matsumoto M (1987) Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas. Jpn J Cancer Res 78:614-620.
6. Nakarai H, Saida T, Shibata Y, Irie RF, Kano K (1987) Expression of heterophile, Paul-Bunnell and Hanganutziu-Deicher antigens on human melanoma cell lines. Int Arch Allergy Appl Immunol 83:160-166.
7. Ohashi Y, Sasabe T, Nishida T, Nishi Y, Higashi H (1983) Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells. Am J Ophthalmol 96:321-325.
8. Tangvoranuntakul P, et al. (2003) Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 100:12045-12050.
9. Rose DP, Boyar AP, Wynder EL (1986) International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58:2363-2371.
10. Giovannucci E, et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571-1579.
11. Fraser GE (1999) Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr 70:532S-538S.
12. Willett WC (2000) Diet and cancer. Oncologist 5:393-404.
13. Tavani A, et al.La VC, Gallus S, Lagiou P, Trichopoulos D, Levi F, Negri E (2000) Red meat intake and cancer risk: A study in Italy. Int J Cancer 86:425-428.
14. Norat T, Lukanova A, Ferrari P, Riboli E (2002) Meat consumption and colorectal cancer risk: Dose-response meta-analysis of epidemiological studies. Int J Cancer 98:241-256.
15. Bosetti C, et al.Micelotta S, Dal Maso L, Talamini R, Montella M, Negri E, Conti E, Franceschi S, La Vecchia C (2004) Food groups and risk of prostate cancer in Italy. Int J Cancer 110:424-428.
16. Zhang J, Kesteloot H (2005) Milk consumption in relation to incidence of prostate, breast, colon, and rectal cancers: Is there an independent effect? Nutr Cancer 53:65-72.
17. Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005) Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 81:1147-1154.
18. Bardor M, Nguyen DH, Diaz S, Varki A (2005) Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 280:4228-4237.
19. Nguyen DH, Tangvoranuntakul P, Varki A (2005) Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J Immunol 175:228-236.
20. Yin J, et al. (2006) Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res 66:2937-2945.
21. Merrick JM, Zadarlik K, Milgrom F (1978) Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolylneuraminic acid. Int Arch Allergy Appl Immunol 57:477-480.
22. Nowak JA, Jain NK, Stinson MW, Merrick JM (1986) Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human Hanganutziu-Deicher serum. Mol Immunol 23:693-700.
23. Morito T, Kano K, Milgrom F (1982) Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases. J Immunol 129:2524-2528.
24. Padler-Karavani V, et al. (2008) Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease. Glycobiology 18:818-830.
25. Prehn RT (1972) The immune reaction as a stimulator of tumor growth. Science 176:170-171.
26. Prehn RT, Prehn LM (1987) The autoimmune nature of cancer. Cancer Res 47:927-932.
27. Prehn RT (1994) Stimulatory effects of immune reactions upon the growths of untransplanted tumors. Cancer Res 54:908-914.
28. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357:539-545.
29. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867.
30. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78.
31. De Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37.
32. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436-444.
33. Mantovani A (2005) Cancer: Inflammation by remote control. Nature 435:752-753.
34. Tan TT, Coussens LM (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 19:209-216.
35. Bui JD, Schreiber RD (2007) Cancer immunosurveillance, immunoediting and inflammation: Independent or interdependent processes? Curr Opin Immunol 19:203-208.
36. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411-423.
37. Kawai T, Kato A, Higashi H, Kato S, Naiki M (1991) Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Res 51:1242-1246.
38. Devine PL, et al. (1991) The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res 51:5826-5836.
39. Hedlund M, et al. (2007) N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol 27:4340-4346.
40. Muchmore EA, Diaz S, Varki A (1998) A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol 107:187-198.
41. Gupta RA, Dubois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11-21.
42. Dannenberg AJ, Subbaramaiah K (2003) Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise. Cancer Cell 4:431-436.
43. Mann JR, Backlund MG, DuBois RN (2005) Mechanisms of disease: Inflammatory mediators and cancer prevention. Nat Clin Pract Oncol 2:202-210.
44. Key TJ, et al. (1999) Mortality in vegetarians and nonvegetarians: Detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr 70:516S-524S.
45. Varki A (2000) A chimpanzee genome project is a biomedical imperative. Genome Res 10:1065-1070.
46. Pardoll DM (2002) Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol 2:227-238.
47. Finn OJ (2008) Cancer immunology. N Engl J Med 358:2704-2715.
48. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183.
49. Naugler WE, Karin M (2008) The wolf in sheep's clothing: The role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14:109-119.
50. Manzi AE, et al. (2000) Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures. Glycobiology 10:669-689.
51. Norgard-Sumnicht K, Bai XM, Esko JD, Varki A, Manzi AE (2000) Exploring the outcome of genetic modifications of glycosylation in cultured cell lines by concurrent isolation of the major classes of vertebrate glycans. Glycobiology 10:691-700.
52. Sonnenburg JL, Van Halbeek H, Varki A (2002) Characterization of the acid stability of glycosidically linked neuraminic acid-Use in detecting de-N-acetyl-gangliosides in human melanoma. J Biol Chem 277:17502-17510.
53. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM (1997) Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565.